enGene Holdings Inc.
NASDAQ:ENGNBiotechnology
Healthcare
$1.85 -1.15%
-$0.02 today
- Market cap
- $123.98M
- Beta
- -0.29
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$0.95
52W Low $1.40High $12.25
Volume 2.81M
Average 1.58M
Balance Sheet
Inspect the capital base behind the business.
Assets
$221.47M
FY 2025 · Annual
-28.8% YoYLiabilities
$53.76M
FY 2025 · Annual
+39.4% YoYEquity
$167.71M
FY 2025 · Annual
-38.5% YoYBalance Sheet
USD
Metric | FY2021 Oct 2021 | FY2022 Oct 2022 | FY2023 Oct 2023 | FY2024 Oct 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.07M | 314.15K | 81.52M | 173M | 50.15M |
| Short-term Investments | 0 | 0 | 76K | 65.4M | 143.66M |
| Net Receivables | 0 | 0 | 2.34M | 1.03M | 2.23M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 1.5M | 7.93M | 5.35M |
| Total Current Assets | 1.57M | 511.8K | 85.44M | 247.36M | 201.39M |
| Property, Plant & Equipment (Net) | 0 | 0 | 589K | 2.91M | 10.19M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 129.67M | 131.53M | 70K | 59.53M | 8.52M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 209.05K | 939K | 860K | 1.37M | 1.36M |
| Total Non-current Assets | 129.88M | 131.53M | 1.52M | 63.81M | 20.08M |
| Total Assets | 131.45M | 132.04M | 86.96M | 311.17M | 221.47M |
| Account Payables | 0 | 0 | 1.16M | 1.41M | 6.69M |
| Short-term Debt | 1.05M | 1.27M | 562K | 1.12M | 10.02M |
| Tax Payables | 0 | 22K | 39K | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 327.45K | 893.51K | 2.69M | 8.65M | 11.2M |
| Total Current Liabilities | 327.45K | 893.51K | 5.26M | 14.66M | 31.98M |
| Long-term Debt | 0 | 0 | 9.22M | 22.47M | 15.32M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 3.73M | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 3.73M | 0 | 0 | 0 |
| Total Non-current Liabilities | 3.73M | 3.73M | 9.22M | 23.9M | 21.78M |
| Total Liabilities | 4.05M | 4.62M | 14.47M | 38.56M | 53.76M |
| Common Stock | 129.67M | 131.53M | 259.37M | 509.81M | 513.28M |
| Retained Earnings | (2.28M) | (4.11M) | (199.59M) | (254.73M) | (372.03M) |
| Accumulated OCI | 0 | 0 | (1.02M) | (1.42M) | (888K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 127.39M | 127.42M | 72.49M | 272.61M | 167.71M |
| Total Debt | 4.16M | 32.11M | 9.78M | 25.02M | 31.8M |
| Net Debt | (1.07M) | (314.15K) | (71.74M) | (147.98M) | (18.36M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $29.8M |
| Short-term Investments | $228.6M |
| Receivables | $2.9M |
| Other Current | $8.6M |
| Total Current Assets | $270.0M |
| PP&E (Net) | $9.4M |
| Long-term Investments | $26.7M |
| Other Non-current | $1.4M |
| Total Non-current Assets | $37.5M |
| Total Assets | $307.5M |
Analysis
Selected assets total $307.5M for Latest. The largest visible component is Short-term Investments at $228.6M, about 74.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 3 | Initial statement of beneficial ownership | Nov 13, 2026 | |
| SC 13G | SC 13G filing | Nov 13, 2026 | |
| 8-K | Current report | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 24, 2026 |
How much cash does ENGN have?
enGene Holdings Inc. (ENGN) reported $50.15M in cash and equivalents in fiscal 2025.
How much debt does ENGN carry?
enGene Holdings Inc. (ENGN) reported $31.80M of total debt, with net debt of -$18.36M.
Continue the stock analysis
Jump to another research area for this company.